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Background: Vitamin D deficiency is an increasingly recognized comorbidity in patients with type 1 diabetes
mellitus (DMT1), suggesting that vitamin D deficiency might play a role in DMT1. We aimed to determine and
compare the vitamin D status of Saudi adults with and without DMT1.
Methods: A total of 60 Saudi adults with DMT1 from the Diabetes Clinics and 60 non-DM, healthy controls were
included in the study. The mean age for those with DMT1 was 25.9 ± 16.1 years versus 36.7 ± 3.6 years among the
controls. We measured serum 25-hydroxy vitamin D (25OHD), calcium, cholesterol, blood glucose, HDL, and
triglycerides and compared the results between the DMT1 group and control subjects.
Results: Both the DMT1 and healthy groups had vitamin D deficiency. The mean levels of 25OHD were significantly
lower in the DMT1 adults than in the controls (28.1 ± 1.4 nmol/L versus 33.4 ± 1.6 nmol/L). In the DMT1 adults,
66.7% were mildly, 31.7% moderately, and 3.3% severely vitamin D deficient as compared with 41.7% (mildly), 31.7%
(moderately), and 5% (severely) in the control group. Overall, 100% of the DMT1 adults and 78% of the healthy
children were vitamin D deficient.
Conclusion: The prevalence of vitamin D deficiency among DMT1 adults was relatively high. Therefore, screening
for vitamin D deficiency and supplementation for this population should be warranted.
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Diabetes mellitus Type 1 (DMT1) is the most common
life-threatening endocrine disorder in children and
young adults worldwide and its incidence appears to be
increasing. Originally coined juvenile diabetes or insulin-
dependent diabetes, DMT1 traditionally has been con-
sidered a pediatric disease. In a recent multicenter US
study, the incidence of DMT1 was approximately 20 per
100,000 among youth less than 20 years of ag with; no
gender differences observed [1]. Currently, there are* Correspondence: aldaghri2011@gmail.com
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reproduction in any medium, provided the orlimited population-based estimates of DMT1 among
adults; however, the medical literature suggests that up
to 40% of new cases of DMT1 occur in persons over the
age of 18 years [2,3]. The rise in the incidence of
diabetes has broken the age limit boundaries and is cur-
rently seen in all age groups.
The observation of Adams and colleagues that symp-
tomatic diabetes occurred more frequently at higher lati-
tudes suggests that vitamin D deficiency might play a role
in DMT1 [4,5]. Several reports showed a higher incidence
of vitamin D deficiency in children and adolescents [6-9]
with DMT1. However, studies examining vitamin D defi-
ciency in DMT1 adults from the Middle East are limited.
A recent study from Saudi Arabia revealed that the inci-
dence of severe vitamin D deficiency was considerably
higher in children with DMT1 [7,10]. The investigatorsral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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significantly lower in children with DMT1 than non-
diabetic children. However, both groups were in the mild
to moderate vitamin D deficiency category [2]. Because of
the high prevalence of vitamin D deficiency in children
and adolescents with DMT1, some reports [4,6] suggested
routine screening for vitamin D status in this population.
Optimal vitamin D status and close follow-up were re-
commended [8,11].
Saudi nationals, particularly women, are not exposed
to the sunlight long enough to synthesize vitamin D due
to the culture requiring clothing to cover most of the
body. Furthermore, many young people are not con-
suming sufficient fresh milk or dairy products fortified
with vitamin D. Hence, it is important to investigate the
vitamin D status and the risk of DMT1 in Saudis adults.
The aim of this study is to assess the vitamin D status of
in Saudi adults with DMT1 in comparison to healthy




The study sample included Saudi subjects recently diag-
nosed with DMT1 and those with established DMT1.
Sixty subjects with DMT1 (more than 5 months du-
ration), and 60 healthy control subjects were randomly
and cross-sectionally selected. Written informed consent
was taken from each subject before study inclusion.
Ethics approval was granted by the Ethics Committee of
the College of Science, King Saud University, Riyadh,
Kingdom of Saudi Arabia (KSA). Participating subjects
were recruited and enrolled in 4 primary health care
centers (PHCCs) within the Riyadh Central Region.
Study subjects were asked to complete a generalized
questionnaire that contains demographic information in-
cluding past and present medical history, and to return
after fasting for more than 10 hours for anthropometry
and blood withdrawal. At the screening visit, blood sam-
ples were examined for levels of sugar and cholesterol.
Subjects who had abnormal levels of these at chemical
laboratory tests were excluded.
Anthropometry and blood collection
Subjects were requested to visit their respective PHCCs
following an overnight fasted state (>10 hours) for anthro-
pometry and blood withdrawal by the PHCC nurse and
physician on duty, respectively. Anthropometry included
height (rounded to the nearest 0.5 cm), weight (rounded
to the nearest 0.1 kg), waist and hip circumference (centi-
meters), and mean systolic and diastolic blood pressure
(mmHg, average of 2 readings). Body mass index (BMI)
was calculated as weight in kilograms divided by height in
square meters. Fasting blood samples were collected andtransferred immediately to a non-heparinized tube for
centrifugation. Collected serum was then transferred to
pre-labeled plain tubes, stored on ice, and delivered to
the Biomarkers Research Program (BRP) in King Saud
University, Riyadh, KSA, for immediate storage at −20°C.
Sample analyses
Fasting glucose, lipid profile, calcium, and phosphorous
were measured using a chemical analyzer (Konelab, Espoo,
Finland). Serum 25(OH)D was measured with a Roche
Elecsys modular analytics Cobas e411 using an elec-
trochemiluminescence immuno assay (Roche Diagnostics,
GmbH, Mannheim, Germany) and commercially available
IDS kits (IDS Ltd, Boldon Colliery, Tyne & Wear, UK).
The inter- and intra-assay coefficients of variation (CV)
for 25 (OH) D ELISA were 5.3% and 4.6%, respectively,
with 100% cross-reactivity to 25 (OH) D3 and 75% cross-
reactivity to 25 (OH) D2. It should be noted that the BRP
laboratory is a participating entity in the Vitamin D
External Quality Assessment Scheme (DEQAS), and
Quality Assurance (QA) standards are maintained by ISO
9000 and 17025, whereas the QA department audits the
BRP laboratory at regular intervals.
Data analysis
Data were analyzed using the Statistical Package for the
Social Sciences version 16.0 (SPSS, Chicago, IL, USA).
Normal continuous variables were presented as mean ±
standard deviation. The paired t-test was used to compare
differences between baseline and 1 year. Spearman’s cor-
relation was done using osteocalcin and serum CrossLaps
as dependent variables. Significance was set at p < 0.05.
Results
We assessed clinical and laboratory findings in 60 adults
with DMT1. The characteristics of the whole group ac-
cording to DM status and vitamin D levels are shown in
Table 1. Anthropometric parameters including age, gen-
der, height, and weight were obtained (Table 1). Of the
total number of subjects, 56.6% of the DMT1 subjects and
53.3% of the healthy adults were males, and 43.4% of the
DMT1 subjects and 46.7% of the healthy adults were
females. The mean age for the DMT1 subjects was 25.9 ±
16.1 years versus 36.7 ± 3.6 years for the healthy controls.
Both groups differed significantly in all anthropometric
measures. Adults with DMT1 had significantly lower
mean BMI and waist and hip circumference (p < 0.001),
but higher waist to hip ratio (WHR) than the healthy
adults. DMT1 adults also had significantly higher fasting
glucose concentrations and HDL-cholesterol (p < 0.001)
than healthy adults. Calcium levels showed statistically
significant differences between DMT1 and non-diabetic
subjects (p = 0.01), though all subjects had calcium
levels within the normal range. Calcium levels were
Table 1 Basic characteristics and vitamin D levels in
diabetic and healthy control adults
Control Type 1 diabetes P value
N 60 60
Gender (M/F) 32/28 34/26 0.71
Age 36.7 ± 3.6 25.9 ± 16.1 <0.001
BMI (kg/m2) 28.2 ± 6.8 26.4 ± 6.1 0.12
Waist (cm) 83.1 ± 13.2 71.4 ± 14.1 <0.001
Hips (cm) 96.1 ± 16.5 80.1 ± 27.0 0.001
Waist-hips ratio 0.96 ± 0.16 0.87 ± 0.18 0.004
Cholesterol (mmol/L) 4.9 ± 1.0 5.0 ± 1.1 0.78
Glucose (mmol/L) 5.2 ± 0.63 13.8 ± 7.7 <0.001
HDL (mmol/L) 0.84 ± 0.34 1.1 ± 0.42 0.002
Triglyceride (mmol/L) 1.5 ± 0.74 1.4 ± 0.86 0.97
LDL (mmol/L) 3.4 ± 0.95 3.5 ± 0.91 0.81
Vitamin D (nmol/L) 33.4 ± 1.6 28.1 ± 1.4 0.03
Vitamin D deficiency (%)
50-25 nmol/L 25 (41.7) 40 (66.7) 0.19
25.0-12.5 nmol/L 19 (31.7) 19 (31.7)
<12.5 nmol/L 3 (5) 2 (3.3)
Calcium (mmol/L) 2.4 ± 0.36 2.2 ± 0.35 0.01
Fish (g/week) 724.9 ± 163.7 150 ± 52.9 <0.001
Liver 224.5 ± 141.2 360 ± 203.2 0.13
Milk
0 glasses/day 26 (43.4) 32 (53.3) 0.16
1-2 glasses/day 25 (41.6) 25 (41.7)
3-4 glasses/day 9 (15.0) 3 (5.0)
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0.035 mmol/L in the DMT1 adults. Lips classified a
level of 25-OH vitamin D above 50 nmol/L (20 ng/mL)
as normal, 26–50 nmol/L (10–20 ng/mL) as a mild
deficiency, 12.5–25 nmol/L (5–10 ng/mL) as moderate,




Waist (cm) −0.07 0.39
Hips (cm) −0.11 0.22
Total cholesterol (mmol/L) 0.03 0.75
Glucose (mmol/L) 0.12 0.16
HDL-cholesterol (mmol/L) 0.03 0.72
Triglycerides (mmol/L) 0.18 0.04
LDL-cholesterol (mmol/L) −0.15 0.16
Ca (mmol/L) −0.07 0.41
p-value <0.05 is significant.[12]. According to this classification, both groups had
vitamin D deficiency and vitamin D levels were signifi-
cantly lower among T1DM cases compared with healthy
adults (p = 0.03). Mean 25OHD levels were 33.4 ±
1.6 nmol/L in the normal controls and 28.1 ± 1.4 nmol/L
in the T1DM group (p = 0.03). Overall, 100% of the
DMT1 and 78% of the healthy adults were vitamin D
deficient.
Daily consumption of vitamin D-rich foods was focused
on milk drinking and fish consumption. DMT1 patients
consumed significantly lower amounts of fish than healthy
patients. The average daily intake of 3–4 glasses/day of
milk was less in the DMT1 subjects than the healthy
adults. As shown in Table 2, vitamin D levels were not
associated with any parameters, but a weak negative asso-
ciation was found with triglycerides (R = −0.18, p = 0.04).
Discussion
To the best of our knowledge, there are no population-
based studies that have examined the association bet-
ween vitamin D and DMT1 in young Saudi adults. Our
participants with DMT1 all had vitamin D deficiency.
The study revealed that vitamin D deficiency was con-
siderably higher in T1DM adults (100%) compared with
non-diabetic patients (78%). A significant difference in
the mean value of vitamin D between the T1DM and
healthy adults was found (p = 0.03). Although vitamin D
deficiency was prevalent in both groups, it was much
higher among the diabetic adults. We believe that vita-
min D, in some fashion, might inhibit the autoimmune
reaction targeted toward cells of the pancreas [13]. Fur-
thermore, impairment of immune system function by a
sub-optimum vitamin D status in infancy could have
long-term effects on immune responses later in life.
These results support other studies demonstrating that
vitamin D deficiency increases the risk of T1DM [14].
The prevalence of vitamin D deficiency was higher in
our cohort (100%) than in previous Western studiesvariable controlling for age
Control T1DM
R P value R P value
60 77
0.01 0.94 −0.06 0.57
−0.03 0.83 −0.07 0.53
−0.03 0.82 0.05 0.68
0.09 0.50 0.03 0.78
−0.05 0.72 0.08 0.48
0.27 0.04 0.02 0.85
−0.12 0.36 −0.19 0.29
0.01 0.97 0.14 0.24
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vitamin D deficiency was 60.5% in a Swiss study [11], 43%
in an Australian study [15], approximately 25% in an Ital-
ian study [16], and 15% in a North American study [8]. In
Qatari children, a study revealed that vitamin D deficiency
was considerably higher in children with T1DM (90.6%)
compared with non-diabetic children (85.3%) [17]. In
Australian children and adolescents with T1DM, the mean
25OHD was 64.6 nmol/L (61.3–67.9) in normal children
and 54.7 nmol/L (50.3–58.9) in children with T1DM [15].
The proportions of 25OHD deficiency were 18% in
normal children and 43% in children with T1DM [15]. In
a Swedish study, the mean 25OHD levels were 96.7 ±
2.7 nmol/L for the control group and 82.5 ± 1.3 nmol/L
for those with T1DM [18]. In a North American study,
25OHD levels were measured in 128 youths with T1DM.
Fifteen percent were vitamin D deficient and 61% were
vitamin D insufficient. Adjusted 25OHD mean levels were
26.8 + 6.7 ng/dL. The investigators showed that vitamin D
deficiency was more prevalent among older children and
those with a longer duration of diabetes [8]. In a Swiss
prospective cross-sectional study, serum 25OHD levels
were measured in 129 diabetic children [11]. Sixty percent
were vitamin D deficient with a mean 25OHD level of
28.8 nmol/L (26–31.6); the number rose to 84% during
winter, whereas there was no correlation with diabetes
control [11]. These variations might be explained by
differences in dietary intake, sun avoidance beha-
viors, geographical environment, skin color, or genetic
predisposition.
Not all studies showed lower vitamin D levels in per-
sons with T1DM compared with the control group.
Serum samples from 110 subjects with T1DM and 153
control subjects were cross-sectionally analyzed and the
25OHD levels were similar among the 2 groups [19].
The median 25OHD level was 20.1 ng/mL (13–37.4) in
the control group and 23 ng/mL (13.8-33.9) in the
T1DM group. However, both groups had sub-optimal
25OHD levels [19]. Littorin et al., [18] found low
25OHD levels in 459 Swedish patients aged between 15
and 34 years who were newly diagnosed with T1DM
compared with age- and location-matched controls. An-
other study from Italy [16] found low 25OHD levels in
88 newly diagnosed children and adolescents. A recently
published paper from India reported similar results [20].
Understanding the nature of low vitamin D levels in
adults with T1DM is important because it may poten-
tially clarify the mechanisms of autoimmune ß-cell
destruction, leading to interventions for the prevention
or delay of insulin dependence by using vitamin D or its
analogues.
Several limitations were faced while this current study
was conducted, including the exact duration and time of
sun exposure, which might affect the results. In ourstudy, mean 25OHD levels in diabetic adults were rela-
tively lower than those published in Western studies
[8,11,15]. This might reflect the high prevalence of
25OHD deficiency and insufficiency in our normal popu-
lation. The high prevalence of vitamin D deficiency might
be related to decreased sun exposure. Despite the fact that
there is ample sunlight throughout the year, in the Middle
East and other Arab countries, time spent outdoors is se-
verely limited. Thus, vitamin D deficiency was highly
prevalent in Saudi population. It has been documented in
a few studies [21,22] that vitamin D status showed a
strong relationship with lifestyle, especially type of clo-
thing worn. Vitamin D status was much better in women
with Western clothing than in women with traditional
veils with the face and hands covered. Vitamin D defi-
ciency was particularly prevalent among veiled women in
Turkey, Lebanon, Jordan, Saudi Arabia, and Iran [21]. The
Saudi population covers their body completely except
their faces. Wearing concealing clothing and restriction of
outdoor activities has been reported previously as a risk
factor for vitamin D deficiency in Saudi Arabian adoles-
cents [23].
Conclusion
The present study revealed that vitamin D deficiency was
higher in adults with T1DM compared with non-diabetic
controls. Moreover, vitamin D deficiency was found to be
common among the Saudi population. The low levels of
vitamin D in the young population have been attributed
mainly to social customs, particularly the avoidance of
sunlight and vitamin D supplements. It will be of interest
for future studies to investigate whether vitamin D supple-
mentation improves glycemic control in vitamin D defi-
cient diabetic adults. Additionally, we suggest the need for
a randomized controlled trial to assess the correlation bet-
ween vitamin D with control and prevention of T1DM.
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